本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Organon & Co

13.75
+0.01000.07%
盤後13.73-0.0200-0.15%19:56 EDT
成交量:176.63萬
成交額:2,427.47萬
市值:36.11億
市盈率:17.34
高:13.76
開:13.74
低:13.73
收:13.74
52周最高:13.76
52周最低:5.69
股本:2.63億
流通股本:2.43億
量比:0.63
換手率:0.73%
股息:0.08
股息率:0.58%
每股收益(TTM):0.7929
每股收益(LYR):0.7200
淨資產收益率:24.04%
總資產收益率:5.67%
市淨率:3.59
市盈率(LYR):19.10

資料載入中...

公司資料

公司名字:
Organon & Co
交易所:
NYSE
成立時間:
1923
員工人數:
10000
公司地址:
30 Hudson Street,Floor 33,Jersey City,New Jersey,United States
郵編:
07302
電話:
傳真:
- -
簡介:
Organon & Co.是一家於2020年3月11日在特拉華州註冊成立的公司。該公司是一家全球性的醫療保健公司,其使命是提供有影響力的藥物和解決方案,讓每一天都更健康。該公司在女性健康和普通藥物領域擁有70多種產品組合,其中包括生物仿製藥,專註於滿足對女性有獨特、不成比例或不同影響的健康需求,同時在140多個國家和地區擴大基本治療的可及性。

董事

名稱
職位
Alan Ezekowitz
Independent Director
Carrie S. Cox
Interim Executive Chair, Independent Director
Cynthia M. Patton
Independent Director
Deborah Leone
Independent Director
Grace Puma
Independent Director
Helene Gayle
Independent Director
Philip Ozuah
Independent Director
Robert Essner
Lead Independent Director
Rochelle B. Lazarus
Independent Director
Shalini Sharp
Independent Director

股東

名稱
職位
Joseph Morrissey
Executive Vice President and Head of Manufacturing and Supply, Interim Chief Executive Officer
Matthew Walsh
Executive Vice President and Chief Financial Officer
Aaron Falcione
Executive Vice President and Chief Human Resources Officer
Daniel Karp
Executive Vice President, Corporate Development
Juan Camilo Arjona Ferreira
Executive Vice President, Head of Research & Development and Chief Medical Officer
Kirke Weaver
Executive Vice President, General Counsel and Corporate Secretary
Rachel Stahler
Executive Vice President and Chief Digital & Growth Officer
Vittorio Nisita
Executive Vice President and Head of Enterprise Services & Solutions